POSTEPY W KARDIOLOGII INTERWENCYJNEJ, vol.8, no.1, pp.75-77, 2012 (Journal Indexed in SCI)
The treatment of acute coronary syndrome patients with high thrombus burden is difficult. Percutaneous coronary interventions increase the frequency of distal embolization in these patients. Glycoprotein Ilb/IIla inhibitors are effective anti-platelet agents and they can be very helpful in such cases. Herein, we present the impact of tirofiban infusion on an infarct-related artery with high thrombotic burden. The thrombus cleared completely without coronary angioplasty.